Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,979 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.
Xiong W, Yu Y, Sun C, Du J, Cai Z, Wang Z, Cao X, Yan Y, Chen J, Huang Y, Jiang Z, Wang H, Niu T, Yang G, Xue H, Li B, Huang H, Li Z, Liu Q, Li F, Bai O, Mao M, Fu R, Wang L, Li C, Chu X, Liu L, Dong Y, Wang L, Luo J, Wei Y, Cui R, Qiu L, Li J, Yi S. Xiong W, et al. Among authors: yan y. Haematologica. 2024 Feb 1;109(2):666-670. doi: 10.3324/haematol.2023.283402. Haematologica. 2024. PMID: 37706332 Free PMC article. No abstract available.
High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia.
Yi S, Yan Y, Jin M, Xiong W, Yu Z, Yu Y, Cui R, Wang J, Wang Y, Lin Y, Jia Y, Zhang D, Wang T, Lv R, Liu W, Sui W, Huang W, Fu M, Xu Y, Deng S, An G, Zou D, Li Z, Shi J, Xiao Z, Wang J, Cheng T, Gale RP, Wang L, Qiu L. Yi S, et al. Among authors: yan y. Leukemia. 2021 Aug;35(8):2412-2415. doi: 10.1038/s41375-021-01124-5. Epub 2021 Jan 22. Leukemia. 2021. PMID: 33483618 Free PMC article. No abstract available.
Prominent immune signatures of T cells are specifically associated with indolent B-cell lymphoproliferative disorders and predict prognosis.
Yi S, Zhang Y, Xiong W, Chen W, Hou Z, Yang Y, Yan Y, Wei Y, Cui R, Wang H, Yu Z, Li H, Li Z, Liu W, Lv R, Wang T, Ru K, Zou D, Shu M, Qiu L, Yu D. Yi S, et al. Among authors: yan y. Clin Transl Immunology. 2020 Jan 22;9(1):e01105. doi: 10.1002/cti2.1105. eCollection 2020. Clin Transl Immunology. 2020. PMID: 31993200 Free PMC article.
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.
Wang J, Yan Y, Xiong W, Song G, Wang Y, Zhao J, Jia Y, Li C, Yu Z, Yu Y, Chen J, Jiao Y, Wang T, Lyu R, Li Q, Ma Y, Liu W, Zou D, An G, Sun Q, Wang H, Xiao Z, Wang J, Qiu L, Yi S. Wang J, et al. Among authors: yan y. Blood Adv. 2022 Jul 12;6(13):4049-4059. doi: 10.1182/bloodadvances.2022007279. Blood Adv. 2022. PMID: 35537114 Free PMC article.
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemia.
Xiong W, Wang Z, Wang T, Yu Y, Huang Y, Sun H, Chen J, Lyu R, Wang H, Yan Y, Wang Q, Liu W, An G, Sui W, Huang W, Zou D, Xiao Z, Wang J, Ouyang G, Qiu L, Yi S. Xiong W, et al. Among authors: yan y. Front Immunol. 2023 May 10;14:1171539. doi: 10.3389/fimmu.2023.1171539. eCollection 2023. Front Immunol. 2023. PMID: 37234167 Free PMC article.
Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial.
Xiong W, Lyu R, Yu Y, Wang T, Yan Y, Wang Y, Liu W, An G, Deng S, Xu Y, Sui W, Huang W, Zou D, Wang J, Qiu L, Yi S. Xiong W, et al. Among authors: yan y. Haematologica. 2024 May 1;109(5):1614-1618. doi: 10.3324/haematol.2023.284588. Haematologica. 2024. PMID: 38205507 Free PMC article. Clinical Trial. No abstract available.
17,979 results
You have reached the last available page of results. Please see the User Guide for more information.